<code id='AF780D26FC'></code><style id='AF780D26FC'></style>
    • <acronym id='AF780D26FC'></acronym>
      <center id='AF780D26FC'><center id='AF780D26FC'><tfoot id='AF780D26FC'></tfoot></center><abbr id='AF780D26FC'><dir id='AF780D26FC'><tfoot id='AF780D26FC'></tfoot><noframes id='AF780D26FC'>

    • <optgroup id='AF780D26FC'><strike id='AF780D26FC'><sup id='AF780D26FC'></sup></strike><code id='AF780D26FC'></code></optgroup>
        1. <b id='AF780D26FC'><label id='AF780D26FC'><select id='AF780D26FC'><dt id='AF780D26FC'><span id='AF780D26FC'></span></dt></select></label></b><u id='AF780D26FC'></u>
          <i id='AF780D26FC'><strike id='AF780D26FC'><tt id='AF780D26FC'><pre id='AF780D26FC'></pre></tt></strike></i>

          entertainment

          entertainment

          author:entertainment    Page View:55891
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          What to know about Virgin Galactic's 1st mission taking paying customers to space
          What to know about Virgin Galactic's 1st mission taking paying customers to space

          1:42TheVirginGalacticSpaceShipTwospaceplaneUnityreturnstoearthaboveSpaceportAmerica,nearTruthandCons

          read more
          Apple is now the first public company to be valued at $3 trillion
          Apple is now the first public company to be valued at $3 trillion

          6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

          read more

          How to use technology to prevent future drug shortages

          TherehasbeenapersistentshortageoftheADHDdrugAdderall.JennyKane/APMyfirstexposuretopharmaceuticalshor